EcoDrugPlus

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSHCOG00000004172
Gene Symbol: ALOX5
3 Cross references
224 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSHCOG00000009254
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSHCOG00000004181
Gene Symbol: LOC109509924
3 Cross references
224 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSHCOG00000003398
Gene Symbol: AVPR1A
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSHCOG00000011651
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Aromatase

Ensembl ID : ENSHCOG00000001526
Gene Symbol: LOC109525752
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2-Like

Ensembl ID : ENSHCOG00000003907
Gene Symbol: LOC109527094
2 Cross references
185 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSHCOG00000000240
Gene Symbol: LOC109515948
3 Cross references
205 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSHCOG00000011414
Gene Symbol: LOC109511644
3 Cross references
196 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSHCOG00000000575
Gene Symbol: LOC109524471
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSHCOG00000014069
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSHCOG00000001431
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).